Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma

被引：7

作者：

Huang, Me ^{[1
]}

Song, Qi ^{[1
]}

Wang, Hao ^{[2
]}

Wang, Haixing ^{[1
]}

Xu, Chen ^{[1
]}

Wang, Xin ^{[1
]}

Jiang, Zhengzeng ^{[1
]}

Wang, Yanqiu ^{[1
]}

Xu, Yifan ^{[1
]}

Su, Jieakesu ^{[1
]}

Zeng, Haiying ^{[1
]}

Tan, Lijie ^{[2
]}

Zhu, Hongguang ^{[3
,4
]}

Jiang, Dongxian ^{[1
]}

Hou, Yingyong ^{[1
,3
,4
,5
]}

机构：

[1] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China

[2] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200032, Peoples R China

[3] Fudan Univ, Sch Basic Med Sci, Dept Pathol, Shanghai 200032, Peoples R China

[4] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China

[5] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Pathol, Shanghai 201700, Peoples R China

来源：

HUMAN PATHOLOGY | 2018年 / 80卷

基金：

中国国家自然科学基金;

关键词：

FGF4; amplification; Clinical stage; Esophageal squamous cell carcinoma (ESCC); Poor prognosis; Fluorescence in situ hybridization (FISH); GENE; CANCERS; EXPRESSION; TRENDS; HST-1; EGFR; EMS1;

D O I：

10.1016/j.humpath.2018.06.009

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

In the present study, we aimed to determine the prognostic impact and clinicopathological feature of FGF4 amplification in patients with esophageal squamous cell carcinoma (ESCC). Fluorescence in situ hybridization with FGF4 probe was analyzed using tissue microarray consisting of representative cores of 267 ESCC cases. FGF4 amplification was observed in 52.8% (141/267) of patients. Patients with FGF4 amplification showed a significantly shorter disease-free survival (DFS) or disease-specific overall survival (OS) compared with those without FGF4 amplification (both P<.05). Moreover, FGF4 amplification was an independent prognostic factor (DFS, P=.036; OS, P=.021) along with clinical stage and lymph node metastasis in multivariate analysis. Among stage I-II or III patients whose DFS was greater than or equal to 24 months (n=125 or 32), patients with FGF4 amplification showed a significantly worse prognosis (OS, P=.027 or P=.010). Moreover, the survival curve of stage I-II patients with FGF4 amplification was identical to stage III patients without FGF4 amplification (DFS, P=.643; OS, P=.707). Taken together, FGF4 amplification was an independent prognostic factor in ESCC patients, and ESCC might have potentially been upstaged by FGF4 amplification. Therefore, FGF4 amplification in combination with clinical stage could be used as a relatively accurate predictor for the 5-year probability of death and recurrence for ESCC patients. (C) 2018 Published by Elsevier Inc.

引用

页码：210 / 218

页数：9

共 37 条

[1] Esophageal and Esophagogastric Junction Cancers, Version 1.2015 [J].

Ajani, Jaffer A. ;

D'Amico, Thomas A. ;

Almhanna, Khaldoun ;

Bentrem, David J. ;

Besh, Stephen ;

Chao, Joseph ;

Das, Prajnan ;

Denlinger, Crystal ;

Fanta, Paul ;

Fuchs, Charles S. ;

Gerdes, Hans ;

Glasgow, Robert E. ;

Hayman, James A. ;

Hochwald, Steven ;

Hofstetter, Wayne L. ;

Ilson, David H. ;

Jaroszewski, Dawn ;

Jasperson, Kory ;

Keswani, Rajesh N. ;

Kleinberg, Lawrence R. ;

Korn, W. Michael ;

Leong, Stephen ;

Lockhart, A. Craig ;

Mulcahy, Mary F. ;

Orringer, Mark B. ;

Posey, James A. ;

Poultsides, George A. ;

Sasson, Aaron R. ;

Scott, Walter J. ;

Strong, Vivian E. ;

Varghese, Thomas K., Jr. ;

Washington, Mary Kay ;

Willett, Christopher G. ;

Wright, Cameron D. ;

Zelman, Debra ;

McMillian, Nicole ;

Sundar, Hema .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (02) :194-227

[2] FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma [J].

Arao, Tokuzo ;

Ueshima, Kazuomi ;

Matsumoto, Kazuko ;

Nagai, Tomoyuki ;

Kimura, Hideharu ;

Hagiwara, Satoru ;

Sakurai, Toshiharu ;

Haji, Seiji ;

Kanazawa, Akishige ;

Hidaka, Hisashi ;

Iso, Yukihiro ;

Kubota, Keiichi ;

Shimada, Mitsuo ;

Utsunomiya, Tohru ;

Hirooka, Masashi ;

Hiasa, Yoichi ;

Toyoki, Yoshikazu ;

Hakamada, Kenichi ;

Yasui, Kohichiroh ;

Kumada, Takashi ;

Toyoda, Hidenori ;

Sato, Shuichi ;

Hisai, Hiroyuki ;

Kuzuya, Teiji ;

Tsuchiya, Kaoru ;

Izumi, Namiki ;

Arii, Shigeki ;

Nishio, Kazuto ;

Kudo, Masatoshi .

HEPATOLOGY, 2013, 57 (04) :1407-1415

[3] MOLECULAR-CLONING AND CHROMOSOMAL MAPPING OF DNA REARRANGED WITH THE PARATHYROID-HORMONE GENE IN A PARATHYROID ADENOMA [J].

ARNOLD, A ;

KIM, HG ;

GAZ, RD ;

EDDY, RL ;

FUKUSHIMA, Y ;

BYERS, MG ;

SHOWS, TB ;

KRONENBERG, HM .

JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :2034-2040

[4] Global incidence of oesophageal cancer by histological subtype in 2012 [J].

Arnold, Melina ;

Soerjomataram, Isabelle ;

Ferlay, Jacques ;

Forman, David .

GUT, 2015, 64 (03) :381-387

[5] The landscape of somatic copy-number alteration across human cancers [J].

Beroukhim, Rameen ;

Mermel, Craig H. ;

Porter, Dale ;

Wei, Guo ;

Raychaudhuri, Soumya ;

Donovan, Jerry ;

Barretina, Jordi ;

Boehm, Jesse S. ;

Dobson, Jennifer ;

Urashima, Mitsuyoshi ;

Mc Henry, Kevin T. ;

Pinchback, Reid M. ;

Ligon, Azra H. ;

Cho, Yoon-Jae ;

Haery, Leila ;

Greulich, Heidi ;

Reich, Michael ;

Winckler, Wendy ;

Lawrence, Michael S. ;

Weir, Barbara A. ;

Tanaka, Kumiko E. ;

Chiang, Derek Y. ;

Bass, Adam J. ;

Loo, Alice ;

Hoffman, Carter ;

Prensner, John ;

Liefeld, Ted ;

Gao, Qing ;

Yecies, Derek ;

Signoretti, Sabina ;

Maher, Elizabeth ;

Kaye, Frederic J. ;

Sasaki, Hidefumi ;

Tepper, Joel E. ;

Fletcher, Jonathan A. ;

Tabernero, Josep ;

Baselga, Jose ;

Tsao, Ming-Sound ;

Demichelis, Francesca ;

Rubin, Mark A. ;

Janne, Pasi A. ;

Daly, Mark J. ;

Nucera, Carmelo ;

Levine, Ross L. ;

Ebert, Benjamin L. ;

Gabriel, Stacey ;

Rustgi, Anil K. ;

Antonescu, Cristina R. ;

Ladanyi, Marc ;

Letai, Anthony .

NATURE, 2010, 463 (7283) :899-905

[6] Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma [J].

Cheng, Caixia ;

Zhou, Yong ;

Li, Hongyi ;

Xiong, Teng ;

Li, Shuaicheng ;

Bi, Yanghui ;

Kong, Pengzhou ;

Wang, Fang ;

Cui, Heyang ;

Li, Yaoping ;

Fang, Xiaodong ;

Yan, Ting ;

Li, Yike ;

Wang, Juan ;

Yang, Bin ;

Zhang, Ling ;

Jia, Zhiwu ;

Song, Bin ;

Hu, Xiaoling ;

Yang, Jie ;

Qiu, Haile ;

Zhang, Gehong ;

Liu, Jing ;

Xu, Enwei ;

Shi, Ruyi ;

Zhang, Yanyan ;

Liu, Haiyan ;

He, Chanting ;

Zhao, Zhenxiang ;

Qian, Yu ;

Rong, Ruizhou ;

Han, Zhiwei ;

Zhang, Yanlin ;

Luo, Wen ;

Wang, Jiaqian ;

Peng, Shaoliang ;

Yang, Xukui ;

Li, Xiangchun ;

Li, Lin ;

Fang, Hu ;

Liu, Xingmin ;

Ma, Li ;

Chen, Yunqing ;

Guo, Shiping ;

Chen, Xing ;

Xi, Yanfeng ;

Li, Guodong ;

Liang, Jianfang ;

Yang, Xiaofeng ;

Guo, Jiansheng .

AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 98 (02) :256-274

[7] HIGH AMPLIFICATION OF THE HST-1 GENE CORRELATES WITH HEMATOGENOUS RECURRENCE AFTER CURATIVE RESECTION OF ESOPHAGEAL-CARCINOMA [J].

CHIKUBA, K ;

SAITO, T ;

UCHINO, S ;

SATO, K ;

MIYAHARA, M ;

TSUDA, H ;

HIROHASHI, S ;

KOBAYASHI, M .

BRITISH JOURNAL OF SURGERY, 1995, 82 (03) :364-367

[8] Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer [J].

Cihoric, N. ;

Savic, S. ;

Schneider, S. ;

Ackermann, I. ;

Bichsel-Naef, M. ;

Schmid, R. A. ;

Lardinois, D. ;

Gugger, M. ;

Bubendorf, L. ;

Zlobec, I. ;

Tapia, C. .

BRITISH JOURNAL OF CANCER, 2014, 110 (12) :2914-2922

[9] Worldwide incidence, mortality and time trends for cancer of the oesophagus [J].

Gupta, Bhawna ;

Kumar, Narinder .

EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (02) :107-118

[10]

Harding James J, 2014, Hepatobiliary Surg Nutr, V3, P168, DOI 10.3978/j.issn.2304-3881.2014.07.03

← 1 2 3 4 →